Skip to main content
Healthcare

STAT+: Pharmalittle: We’re reading about CVS plans to split up, FDA inspections in India and China and more

STAT+: Pharmalittle: We’re reading about CVS plans to split up, FDA inspections in India and China and more

Feed excerpt — reported by STAT News

The Trump administration will survey key components of pharmaceutical production in order to identify domestic supply chain vulnerabilities.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at STAT News →

Original Source

This article was syndicated from STAT News. All rights remain with the original publisher.